- AbbVie Inc. (ABBV)
- JPMorgan Chase & Co. (JPM)
- Merck & Company Inc. (MRK)
- PepsiCo Inc. (PEP)
- Procter & Gamble Company (The) (PG)
- Target Corporation (TGT)
- Exchange Income Corporation (EIF)
Q: The initial investment on these and others has doubled. I do not require the funds immediately. I know these are outstanding companies. Each makes up 2% to 3% of the portfolio that is up by 10.5%. In this environment do you still abide by the statement "let the winners run", even to this extent. Should they be trimmed back to the initial cost, or should they be replaced? There are sixty positions in the portfolio balanced through all 11 sectors. I am a 77 year old dividend value investor.
Thank you for all your great input
Stanley
Thank you for all your great input
Stanley